[1]王建勋,项道满,胡兰香,等. 超未成熟儿视网膜病变术后屈光状态分析[J].眼科新进展,2015,35(7):649-651.[doi:10.13389/j.cnki.rao.2015.0177]
　WANG Jian-Xun,XIANG Dao-Man,HU Lan-Xiang,et al. Refractive outcome of retinopathy of prematurity in extremely low birth weight infants after intravitreal injection of bevacizumab[J].Recent Advances in Ophthalmology,2015,35(7):649-651.[doi:10.13389/j.cnki.rao.2015.0177]
点击复制

 超未成熟儿视网膜病变术后屈光状态分析
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
35卷
期数:
2015年7期
页码:
649-651
栏目:
应用研究
出版日期:
2015-07-05

文章信息/Info

Title:
 Refractive outcome of retinopathy of prematurity in extremely low birth weight infants after intravitreal injection of bevacizumab
作者:
 王建勋; 项道满; 胡兰香; 陈锋; 龙静姬; 宋生芳
 510623　广东省广州市，广州市妇女儿童医疗中心眼科
Author(s):
 WANG Jian-Xun ;  XIANG Dao-Man;  HU Lan-Xiang ;  CHEN Feng ;  LONG Jing-Ji ;  SONG Sheng-Fang
 Department of Ophthatmology, Guangzhou Women and Children Medical Center, Guangzhou 510623 , Guangdong Province , China
关键词:
 ; 早产儿视网膜病变; 屈光不正; 超未成熟儿; 婴幼儿; 抗血管内皮生长因子药物
Keywords:
 ; retinopathy of prematurity;  refractive errors;  extremely low birth weight; infants ;  anti-vascular endothelial growth factor drug
DOI:
10.13389/j.cnki.rao.2015.0177
文献标志码:
A
摘要:
 目的　研究出生体质量＜１０００ｇ的早产儿视网膜病变患儿经过抗血管内皮生长因子玻璃体内注射后矫正胎龄６个月大时的眼位、注视功能及屈光状态情况。方法　横断面研究，回顾性队列研究。出生体质量＜１０００ｇ、因早产儿视网膜病变接受抗血管内皮生长因子玻璃体内注射的３２例（６４眼）患儿，于矫正胎龄６个月大时检查其注视功能、眼位，并散瞳验光。按治疗前眼底有无纤维增殖进行分组，观察两组屈光性弱视发生风险有无统计学差异。结果　矫正胎龄６个月大时，３２例６４眼中近视眼者２９眼（４５．３％），近视度数为－０．７５～－４．００（－２．０３±０．７１）ＤＳ；远视眼３２眼（５０．０％），远视度数为＋１．００～＋４．００（＋１．７８±０．７６）ＤＳ；存在或合并散光者２８眼（４３．８％），散光度数为１．００～６．００（２．３９±１．１３）ＤＣ。所有患儿均为正位眼且中心注视，无注视抑制；治疗前眼底纤维增殖组中，有屈光性弱视风险的比例为７５．０％（１２／１６）；无纤维增殖组中，有屈光性弱视风险的比例为２５．０％（４／１６），两者相比差异具有统计学意义（Ｐ＝０．０３２）。结论　出生体质量＜１０００ｇ早产儿接受抗血管内皮生长因子玻璃体内注射术后矫正胎龄６个月大时，表现出中心注视及正位眼，无注视抑制。治疗前眼底纤维增殖组发生屈光性弱视的风险大于无纤维增殖组。
Abstract:
 Objective To observe ocular position , fixation ability , and refractive error of retinopathy of prematurity ( ROP) in infants with birth mass < 1000 g at 6 months ( corrected age) , who had received intravitreal injection of bevacizumab. Methods This is a cross-sectional and retrospective cohort study from a single center. Thirty-two extremely low birth weight infants with ROP got intravitreal injection of bevacizumab. At 6 months ( corrected age) , ocular position, fixation ability were measured. Meanwhile refractive data from retinoscopy under ciliary muscles paralyzed were recorded. These infants were classified int0 2 groups by the fact that the extraretinal fibrovascular proliferation was occurred or not before surgery. Results In 64 eyes of 32 infants,29 eyes (45. 3% ) were myopia,the myopic degree was from - 0. 75 DS to -4. 00 DS , mean ( - 2. 03 +0. 71 ) DS ; 32 eyes ( 50. 0% ) were hyperopia , the hyperopic degree was from + 1. 00 DS to +4. 00 DS.mean ( + 1. 78 +0. 76) DS ;28 eyes (43. 8% ) presented astigmatism , the astigmatism degree was from l. 00 DC t0 6. 00 DC , mean ( 2. 39 + 1. 13 ) DC. All patients showed orthophoria and central steady maintain fixation. There was no fixation suppression. The incidence of amblyopia due to severe refractive error in infants with extraretinal fibrovascular proliferation ( 75. 0% . 12/16) was higher than that in infants without extraretinal fibrovascular proliferation ( 25. 0% . 4/16 ) . Conclusion Infants with birth mass < 1000 g with ROP can develop orthophoria and quality fixation at 6 months ( corrected age) and there is no fixation suppression in these infants. Extraretinal fibrovascular proliferation before surgery may be a risk for severe refractive error.

相似文献/References:

[1]杜安杰 任兵 高晓唯 付燕 赵旭东 郭继华.氨基胍对氧诱导的视网膜病变小鼠视网膜神经细胞的保护作用[J].眼科新进展,2012,32(12):000.
[2]王宗华 董文丽 陈思扬.早产儿视网膜病变间接检眼镜激光治疗及危险因素分析[J].眼科新进展,2012,32(12):000.
[3]田妮 郭海科 项道满 陈锋 卢艳华.数字化双目间接检眼镜检查系统在早产儿视网膜病变筛查中的应用[J].眼科新进展,2012,32(12):000.
[4]李蓉 王雨生.早期治疗早产儿视网膜病变的多中心临床试验[J].眼科新进展,2012,32(3):000.
[5]彭娟 沙翔垠 杨瑞明 郑瑜.妊娠并发症及围产期感染与早产儿视网膜病变的关系[J].眼科新进展,2012,32(4):000.
[6]王淋淋 唐兰芬 谭建新 阮豫才 方玉兰.曲尼司特抑制早产儿视网膜病变大鼠模型血管新生和纤维化的实验研究[J].眼科新进展,2013,33(10):000.
[7]韩丽英 李兵.IGF-1对大鼠未成熟视网膜新生血管形成的影响[J].眼科新进展,2013,33(10):000.
[8]刘平 苏胜. 白内障蛋白质组学研究的现状及未来研究方向[J].眼科新进展,2014,34(1):001.
[9]杨宝娣 宋艳萍 陈中山 丁琴. 微脉冲半导体激光对兔视网膜色素上皮细胞阈值下光凝的光生物调制效应[J].眼科新进展,2014,34(1):005.
[10]赖伟霞 梁皓 谭少健 李霞 邹文进 蒋林志. 钙调素在正常人及不同年龄白内障患者晶状体上皮细胞中的表达[J].眼科新进展,2014,34(1):010.
[11]张国明 李娜 张福燕. 早产儿视网膜病变和足月新生儿眼病筛查指南[J].眼科新进展,2014,34(2):101.
[12]徐文芹,王雨生. IGF-1/IGFBP-3在早产儿视网膜病变中的作用及其应用[J].眼科新进展,2014,34(9):889.[doi:10.13389/j.cnki.rao.2014.0246]
[13]王宗华,李秋平,白华,等. 早产儿视网膜病变自然消退和进展的影响因素研究[J].眼科新进展,2015,35(2):168.[doi:10.13389/j.cnki.rao.2015.0045]
　WANG Zong-Hua,LI Qiu-Ping,BAI Hua,et al. Influencing factors of spontaneous regression and progression of retinopathy of prematurity[J].Recent Advances in Ophthalmology,2015,35(7):168.[doi:10.13389/j.cnki.rao.2015.0045]
[14]李晓琴,王雨生,张自峰. 感染/炎症在早产儿视网膜病变中的作用[J].眼科新进展,2015,35(2):191.[doi:10.13389/j.cnki.rao.2015.0052]
　LI Xiao-Qin,WANG Yu-Sheng,ZHANG Zi-Feng. Role of infection/inflammation in retinopathy of prematurity[J].Recent Advances in Ophthalmology,2015,35(7):191.[doi:10.13389/j.cnki.rao.2015.0052]
[15]李晓琴,张自峰,王雨生,等. 脂多糖诱导炎症对大鼠氧诱导视网膜病变的影响[J].眼科新进展,2015,35(4):301.[doi:10.13389/j.cnki.rao.2015.0081]
　LI Xiao-Qin,ZHANG Zi-Feng,WANG Yu-Sheng,et al. Effects of LPS-induced inflammation on oxygen-induced retinopathy in rats[J].Recent Advances in Ophthalmology,2015,35(7):301.[doi:10.13389/j.cnki.rao.2015.0081]
[16]杨波,郁梅. 玻璃体内注射雷珠单抗治疗早产儿视网膜病变疗效观察[J].眼科新进展,2015,35(7):674.[doi:10.13389/j.cnki.rao.2015.0184]
　YANG Bo,YU Mei. Intravitreal injection of ranibizumab for retinopathy of prematurity[J].Recent Advances in Ophthalmology,2015,35(7):674.[doi:10.13389/j.cnki.rao.2015.0184]

备注/Memo

备注/Memo:
 广州市医药卫生科技重大项目（编号：２０１１０２Ａ２１２０３２）
更新日期/Last Update: 2015-07-03